Cargando…

Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events

Thousands of long non-coding RNAs (lncRNAs) lie interspersed with coding genes across the genome, and a small subset has been implicated as downstream effectors in oncogenic pathways. Here we make use of transcriptome and exome sequencing data from thousands of tumours across 19 cancer types, to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashouri, Arghavan, Sayin, Volkan I., Van den Eynden, Jimmy, Singh, Simranjit X., Papagiannakopoulos, Thales, Larsson, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093340/ https://www.ncbi.nlm.nih.gov/pubmed/28959951 http://dx.doi.org/10.1038/ncomms13197

Ejemplares similares

MicroRNAs: regulators of oncogenesis and stemness
por: Papagiannakopoulos, Thales, et al.
Publicado: (2008)

Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric
por: Van den Eynden, Jimmy, et al.
Publicado: (2017)

Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution
por: Van den Eynden, Jimmy, et al.
Publicado: (2016)

Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice
por: Petersen, Dennis R., et al.
Publicado: (2018)

Transcriptional profiling of the rat nucleus accumbens after modest or high alcohol exposure
por: Morud, Julia, et al.
Publicado: (2017)

Lack of detectable neoantigen depletion signals in the untreated cancer genome
por: Van den Eynden, Jimmy, et al.
Publicado: (2019)

Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic
por: de Schaetzen van Brienen, Louise, et al.
Publicado: (2021)

Metabolic features of cancer cells in NRF2 addiction status
por: Okazaki, Keito, et al.
Publicado: (2020)

Limited evidence for evolutionarily conserved targeting of long non-coding RNAs by microRNAs
por: Alaei-Mahabadi, Babak, et al.
Publicado: (2013)

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018)

A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
por: Deng, Yulan, et al.
Publicado: (2018)

Non-Coding RNAs in Retinoic Acid as Differentiation and Disease Drivers
por: García-Padilla, Carlos, et al.
Publicado: (2021)

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature
por: Fredriksson, Nils Johan, et al.
Publicado: (2017)

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
por: Sayin, Volkan I, et al.
Publicado: (2017)

Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts
por: Vyatkin, Alexey D., et al.
Publicado: (2022)

Integrative analysis reveals driver long non-coding RNAs in osteosarcoma
por: Luo, Zhenguo, et al.
Publicado: (2019)

Emerging Roles of Long Non-Coding RNAs as Drivers of Brain Evolution
por: Zimmer-Bensch, Geraldine
Publicado: (2019)

Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer
por: Ortiz-Pedraza, Yunuen, et al.
Publicado: (2020)

Non-coding RNAs: Key players in T cell exhaustion
por: Li, Kun, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis
por: Ching, Travers, et al.
Publicado: (2016)

Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights
por: Ashouri, Arghavan, et al.
Publicado: (2023)

Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
por: Zhao, Ning, et al.
Publicado: (2022)

Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation
por: Panzeri, Ilaria, et al.
Publicado: (2015)

Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers
por: Elliott, Kerryn, et al.
Publicado: (2018)

Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis
por: Kiang, Karrie Mei-Yee, et al.
Publicado: (2015)

A Catalogue of Putative cis-Regulatory Interactions Between Long Non-coding RNAs and Proximal Coding Genes Based on Correlative Analysis Across Diverse Human Tumors
por: Basu, Swaraj, et al.
Publicado: (2018)

Rapid modeling of cooperating genetic events in cancer through somatic genome editing
por: Sánchez-Rivera, Francisco J., et al.
Publicado: (2014)

Panning for Long Noncoding RNAs
por: Zhu, Shanshan, et al.
Publicado: (2013)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

Long non-coding RNAs as pan-cancer master gene regulators of associated protein-coding genes: a systems biology approach
por: Saleembhasha, Asanigari, et al.
Publicado: (2019)

Comprehensive analysis of key genes, microRNAs and long non‐coding RNAs in hepatocellular carcinoma
por: Shi, Baoqi, et al.
Publicado: (2018)

Non-coding RNAs: a key to future personalized molecular therapy?
por: Galasso, Marco, et al.
Publicado: (2010)

Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis
por: Yu, Zhun, et al.
Publicado: (2023)

Long non-coding RNAs: key regulators of liver and kidney fibrogenesis
por: Han, Su-hyang, et al.
Publicado: (2023)

Autophagy-Modulating Long Non-coding RNAs (LncRNAs) and Their Molecular Events in Cancer
por: Islam Khan, Md Zahirul, et al.
Publicado: (2019)

LGG-07. Novel CRISPR/Cas9 induced KIAA1549:BRAF fusion model for preclinical studies of pediatric gliomas
por: Patel, Krupesh, et al.
Publicado: (2022)

Detection of a MicroRNA Signal in an In Vivo Expression Set of mRNAs
por: Liu, Tsunglin, et al.
Publicado: (2007)

Pan-cancer detection of driver genes at the single-patient resolution
por: Nulsen, Joel, et al.
Publicado: (2021)

The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation
por: Cianflone, Eleonora, et al.
Publicado: (2022)

Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
por: Elliott, Kerryn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kuruvfhocksgnrq15clnhahj3h